SRB Corp’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,344
| Closed | -$697K | – | 38 |
|
|
2024
Q1 | $697K | Buy |
1,344
+262
| +24% | +$130K | 0.04% | 63 |
|
|
2023
Q4 | $510K | Buy |
1,082
+76
| +8% | +$35.1K | 0.03% | 78 |
|
|
2023
Q3 | $438K | Buy |
1,006
+46
| +5% | +$20.9K | 0.03% | 85 |
|
|
2023
Q2 | $427K | Buy |
960
+214
| +29% | +$98.7K | 0.03% | 87 |
|
|
2023
Q1 | $343K | Sell |
746
-194
| -21% | -$92.3K | 0.02% | 92 |
|
|
2022
Q4 | $482K | Buy |
940
+58
| +7% | +$29.4K | 0.03% | 21 |
|
|
2022
Q3 | $400K | Buy |
+882
| New | +$422K | 0.03% | 38 |
|
|
2022
Q2 | – | Sell |
-3,203
| Closed | -$1.57M | – | 79 |
|
|
2022
Q1 | $1.57M | Hold |
3,203
| – | – | 0.09% | 27 |
|
|
2021
Q4 | $1.49M | Sell |
3,203
-1,305
| -29% | -$549K | 0.08% | 33 |
|
|
2021
Q3 | $1.68M | Buy |
+4,508
| New | +$1.71M | 0.1% | 27 |
|
|
2021
Q1 | – | Sell |
-2,414
| Closed | -$775K | – | 114 |
|
|
2020
Q4 | $775K | Buy |
2,414
+354
| +17% | +$109K | 0.06% | 128 |
|
|
2020
Q3 | $553K | Buy |
2,060
+310
| +18% | +$83.4K | 0.05% | 101 |
|
|
2020
Q2 | $460K | Hold |
1,750
| – | – | 0.04% | 136 |
|
|
2020
Q1 | $398K | Buy |
+1,750
| New | +$477K | 0.04% | 77 |
|
|
2018
Q4 | – | Sell |
-2,035
| Closed | -$558K | – | 162 |
|
|
2018
Q3 | $558K | Sell |
2,035
-252
| -11% | -$65.4K | 0.06% | 51 |
|
|
2018
Q2 | $544K | Buy |
2,287
+1,414
| +162% | +$327K | 0.06% | 22 |
|
|
2018
Q1 | $192K | Hold |
873
| – | – | 0.02% | 141 |
|
|
2017
Q4 | $196K | Sell |
873
-41
| -4% | -$8.73K | 0.03% | 128 |
|
|
2017
Q3 | $174K | Sell |
914
-114
| -11% | -$21.7K | 0.02% | 147 |
|
|
2017
Q2 | $193K | Sell |
1,028
-78
| -7% | -$14K | 0.03% | 50 |
|
|
2017
Q1 | $183K | Sell |
1,106
-114
| -9% | -$18.1K | 0.03% | 56 |
|
|
2016
Q4 | $175K | Hold |
1,220
| – | – | 0.02% | 88 |
|
|
2016
Q3 | $153K | Buy |
1,220
+154
| +14% | +$19.9K | 0.02% | 126 |
|
|
2016
Q2 | $140K | Hold |
1,066
| – | – | 0.02% | 101 |
|
|
2016
Q1 | $148K | Sell |
1,066
-39
| -4% | -$5.21K | 0.02% | 104 |
|
|
2015
Q4 | $154K | Buy |
1,105
+42
| +4% | +$5.79K | 0.03% | 19 |
|
|
2015
Q3 | $149K | Buy |
1,063
+172
| +19% | +$25.8K | 0.02% | 95 |
|
|
2015
Q2 | $146K | Sell |
891
-278
| -24% | -$44.4K | 0.02% | 60 |
|
|
2015
Q1 | $181K | Hold |
1,169
| – | – | 0.03% | 19 |
|
|
2014
Q4 | $147K | Sell |
1,169
-69
| -6% | -$8.53K | 0.02% | 118 |
|
|
2014
Q3 | $148K | Buy |
+1,238
| New | +$142K | 0.02% | 20 |
|
Other funds holding ELV
SRB Corp's ELV Position: Q2 2024 in Review
SRB Corp sold out of Elevance Health (ELV) in Q2 2024, closing a stake of 1,344 shares — an estimated $697K sold.
SRB Corp first reported a position in ELV in Q3 2014 and held it in 31 quarters. The position peaked at $1.68M in Q3 2021. 1,706 funds tracked by Wall St. Rank hold ELV as of Q2 2024.
- SRB Corp reported no remaining Elevance Health position as of Q2 2024 after selling out during the quarter.
- SRB Corp sold 1,344 Elevance Health shares in Q2 2024, an estimated $697K.
- SRB Corp first reported a position in Elevance Health in Q3 2014 and held it in 31 quarters.
- SRB Corp's Elevance Health position peaked at $1.68M in Q3 2021.
- 1,706 funds tracked by Wall St. Rank held Elevance Health as of Q2 2024.
Based on SRB Corp's 13F filing for Q2 2024, filed 14 Aug 2024.